J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dias, A. L. T.
Right arrow Articles by Paula, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dias, A. L. T.
Right arrow Articles by Paula, C. R.
Agricola
Right arrow Articles by Dias, A. L. T.
Right arrow Articles by Paula, C. R.
J Med Microbiol 55 (2006), 1693-1699; DOI: 10.1099/jmm.0.46789-0
© 2006 Society for General Microbiology
ISSN 1473-5644

Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates

Amanda L. T. Dias1,2, Flavia E. Matsumoto1, Marcia S. C. Melhem3, Eriques G. da Silva1, Marcos E. Auler1, Antonio M. de Siqueira2 and Claudete R. Paula1

1 Departamento de Microbiologia, Laboratório de Micologia, Instituto de Ciências Biomédicas II, Universidade de São Paulo (USP), São Paulo-SP, Brazil

2 Departamento de Ciências Biológicas, Laboratório de Microbiologia, Universidade Federal de Alfenas-MG, Alfenas-MG, Brazil

3 Instituto Adolfo Lutz, São Paulo-SP, Brazil

Correspondence
Claudete R. Paula
crpmicol{at}uol.com.br

Received 18 June 2006
Accepted 15 August 2006

A prospective study was performed to evaluate the correlation between the proposed standard of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing (AFST-EUCAST) (document 7.1) and the commercial system Etest for determining the MICs of flucytosine, amphotericin B, fluconazole, itraconazole and voriconazole for a collection of 100 clinical and environmental isolates of Cryptococcus neoformans. The agreements among Etest MICs within ±2 log2 dilutions of AFST-EUCAST standard MICs were greater for flucytosine, fluconazole and voriconazole (76, 78 and 88 %, respectively) than for amphotericin B (5 %), the lowest agreement, and itraconazole (67 %). Overall, the correlation coefficients were statistically significant (P<0.05), and it is suggested that the Etest and AFST-EUCAST method are reliable alternatives and present good correlation for all drugs evaluated except amphotericin B. However, the observed differences related to MICs for susceptible, susceptible dose dependent and resistant strains between the methods suggest that it will be necessary to carry out further studies, including assessment of interlaboratory agreement and correlation of MICs by different methods with in vivo response.

Abbreviations: AFST-EUCAST, Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing; CLSI, Clinical and Laboratory Standards Institute; R, resistant; S, susceptible; S-DD, susceptible dose-dependent.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2006 Society for General Microbiology.